跳至主要内容
临床试验/JPRN-jRCTs041190005
JPRN-jRCTs041190005已完成未知

Comparative study between Tokisyakuyakusan and mecobalamin for the efficacy in patients with olfactory dysfunction post-respiratory infection. - TSS

Miwa Takaki0 个研究点目标入组 82 人开始时间: 2019年4月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
82

研究概览

简要总结

This study demonstrated that there was no difference the effects of Toki-shakuyakusa and mecobalamin on post infectious olfactory dysfunctions at 24 weeks after the start of administration.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 65age old(—)
性别
All

入选标准

  • 1) Patients with olfactory dysfunction post-respiratory infection who have developed from at least four weeks ago and within less than one year.
  • 2) Patients aged 20 years old or more and 65 years old or less.
  • 3) Gender unquestioned
  • 4) Outpatient
  • 5) Patients with olfactory dysfunction who have odor recognition thresholds by T&T olfactometry as 2.6 and more (moderate or severe dysosmia)
  • 6) Patients who have given voluntary written informed consent.

排除标准

  • 1) Patients who have rhinosinusitis which is subjected to effect on olfactory dysfunction post-respiratory infection.
  • 2) Patients who used Tokisyakuyakusan or mecobalamin within the last two weeks (It will be eligible if they do not use those medicine for at least two weeks).
  • 3) Patients who are pregnant, suspected to be pregnant or breastfeeding.
  • 4) Patients who desire to bear children
  • 5) Patients who are considered not to be eligible by the investigator.

研究者

发起方
Miwa Takaki

相似试验